4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-002838
Chief Business Officer gave up 6,421 shares (to pay taxes)
- Chief Business Officer acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/doc4.xml…